Trevi Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Trevi Therapeutics (NASDAQ:TRVI) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.09. The company's past performance shows a trend of beating EPS estimates but this has not always led to a positive impact on the share price. The stock is currently trading at $1.525 and has seen a 23.32% decrease over the last 52-week period.
November 08, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trevi Therapeutics is expected to report an EPS of $-0.09. Despite past EPS beats, the stock price has not consistently increased. The stock has decreased by 23.32% over the last 52 weeks.
Trevi Therapeutics has a history of beating EPS estimates, but this has not always resulted in a positive impact on the share price. Given the stock's negative performance over the past year, investors may be bearish going into this earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100